Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
British Journal of Cancer
|
September 1, 1999
Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding
N J Curtin, K J Bowman, R N Turner, et al.
Journal of Medicinal Chemistry
|
November 7, 2000
Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase
A W White, R Almassy, A H Calvert, et al.
British Journal of Cancer
|
July 7, 2011
Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines
A Peasland, L-Z Wang, E Rowling, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 31, 2000
Resistance-modifying agents. Part 7: 2,6-disubstituted-4,8-dibenzylaminopyrimido[5,4-d]pyrimidines that inhibit nucleoside transport in the presence of alpha1-acid glycoprotein (AGP)
H C Barlow, K J Bowman, N J Curtin, et al.
Journal of Medicinal Chemistry
|
November 7, 2000
Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O(6)-(1-cyclopentenylmethyl)guanine
R J Griffin, C E Arris, C Bleasdale, et al.
British Journal of Cancer
|
October 28, 2010
Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699
R A Daniel, A L Rozanska, E A Mulligan, et al.
Breast (Edinburgh, Scotland)
|
October 11, 2011
Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design
W Eiermann, J Bergh, F Cardoso, et al.
Journal of Medicinal Chemistry
|
August 24, 2000
Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles
C E Arris, F T Boyle, A H Calvert, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
British Journal of Cancer
|
September 1, 1999
Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding
N J Curtin, K J Bowman, R N Turner, et al.
Journal of Medicinal Chemistry
|
November 7, 2000
Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase
A W White, R Almassy, A H Calvert, et al.
British Journal of Cancer
|
July 7, 2011
Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines
A Peasland, L-Z Wang, E Rowling, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 31, 2000
Resistance-modifying agents. Part 7: 2,6-disubstituted-4,8-dibenzylaminopyrimido[5,4-d]pyrimidines that inhibit nucleoside transport in the presence of alpha1-acid glycoprotein (AGP)
H C Barlow, K J Bowman, N J Curtin, et al.
Journal of Medicinal Chemistry
|
November 7, 2000
Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O(6)-(1-cyclopentenylmethyl)guanine
R J Griffin, C E Arris, C Bleasdale, et al.
British Journal of Cancer
|
October 28, 2010
Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699
R A Daniel, A L Rozanska, E A Mulligan, et al.
Breast (Edinburgh, Scotland)
|
October 11, 2011
Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design
W Eiermann, J Bergh, F Cardoso, et al.
Journal of Medicinal Chemistry
|
August 24, 2000
Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles
C E Arris, F T Boyle, A H Calvert, et al.
Page
of 5